Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Sørensen AL, Mikkelsen SU, Knudsen TA, Bjørn ME, Andersen CL, Bjerrum OW, Brochmann N, Patel DA, Gjerdrum LMR, El Fassi D, Kruse TA, Larsen TS, Mourits-Andersen HT, Nielsen CH, Ellervik C, Pallisgaard N, Thomassen M, Kjær L, Skov V, Hasselbalch HC.
Sørensen AL, et al. Among authors: kruse ta.
Haematologica. 2020 Sep 1;105(9):2262-2272. doi: 10.3324/haematol.2019.235648.
Haematologica. 2020.
PMID: 33054051
Free PMC article.
Clinical Trial.